InspireMD Announces Important Clincial Data from MASTER, CARENET Trials: Pooled Data Showed Statistically Significant Mortality Benefit
December 15, 2014 at 08:37 AM EST
InspireMD, Inc. (NYSE: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced results ...
